Alterations of evoked potentials link research in attention dysfunction to peptide response symptoms of schizophrenia.
D000161:Acoustic Stimulation; D001288:Attention / Q000187:drug effects*; D004723:Endorphins / Q000494:pharmacology; D005071:Evoked Potentials / Q000187:drug effects; D006801:Humans; D009020:Morphine / Q000494:pharmacology; D009271:Naltrexone / Q000494:pharmacology; D010146:Pain / Q000503:physiopathology; D010455:Peptides / Q000494:pharmacology*; D012559:Schizophrenia / Q000503:physiopathology*; D012565:Schizophrenic Psychology
D004723:Endorphins; D010455:Peptides; D009271:Naltrexone; D009020:Morphine